You are here: Home / About Us / News and Media / 2011 News / Mount Sinai Hospital opens new Centre for Regenerative Medicine
Share:

Mount Sinai Hospital opens new Centre for Regenerative Medicine

Canada’s leading scientists and clinicians to develop novel strategies for bone and tissue regeneration

March 24, 2011 — Mount Sinai Hospital’s internationally respected Samuel Lunenfeld Research Institute today announced the opening of a new Centre for Regenerative Medicine and Musculoskeletal Research at 25 Orde Street. The Honourable Tony Clement, Federal Minister of Industry and The Honourable Glen Murray, Ontario Minister of Research and Innovation will participate in the ribbon cutting at 4 pm.

“Through their investigations into the biology of stem cells and the mechanisms behind tissue regeneration, Lunenfeld scientists are leading research that will open the door to improved therapies and possible cures for spinal cord injury, damaged joints, arthritis, diabetes and Parkinson’s disease, among other illnesses,” said Dr. Jim Woodgett, Director of Research at the Lunenfeld.

The new Centre will include sophisticated laboratories and groundbreaking technologies to advance the research of Mount Sinai’s world-renowned experts (scientists, orthopaedic surgeons and pathologists) in stem cell biology, arthritis, sarcoma, osteoporosis and more.

The initiative represents Canada’s first collaborative effort involving scientists and clinicians dedicated to discovering and applying new knowledge into bone and tissue regeneration, including the development of joint replacements.

“This Centre will help Ontario build its reputation as an international centre of medical research and deliver better healthcare to all Ontarians,” said Minister of Research and Innovation Glen Murray. “The research that happens here — especially around bone and tissue regeneration — will be increasingly important to Ontario’s aging population.”

The new Centre for Regenerative Medicine and Musculoskeletal Research was funded by the Canada Foundation for Innovation, the Ontario Ministry of Research of Innovation and the Ontario Innovation Trust.

Mount Sinai Hospital has established itself as a leader in this area of medicine, having been the first to discover a new method of creating stem cells, with the goal of curing illnesses such as peripheral vascular disease and osteoarthritis.

The new Centre will include 10,000 square feet of research, expanding on the Lunenfeld’s existing facilities at 25 Orde Street, which include over 155,000 square feet of laboratory space devoted to the study of common illnesses that impact millions of Canadians.